Literature DB >> 31336175

AS1411-conjugated gold nanoparticles affect cell proliferation through a mechanism that seems independent of nucleolin.

Samaneh Kabirian-Dehkordi1, Mounira Chalabi-Dchar2, Hichem C Mertani2, Dominique Le Guellec3, Bernard Verrier3, Jean-Jacques Diaz2, Masoud A Mehrgardi4, Philippe Bouvet5.   

Abstract

G-rich oligonucleotide, AS1411, has been shown to interact with nucleolin and to inhibit cancer cell proliferation and tumor growth. This antiproliferative action is increased when AS1411 is conjugated to different types of nanoparticles. However, the molecular mechanisms are not known. In this work, we show in several cell lines that optimized AS1411-conjugated gold nanoparticles (GNS-AS1411) inhibit nucleolin expression at the RNA and protein levels. We observed an alteration of the nucleolar structure with a decrease of ribosomal RNA accumulation comparable to what is observed upon nucleolin knock down. However, the expression of genes involved in cell cycle and the cell cycle blockage by GNS-AS1411 are not regulated in the same way as that in cells where nucleolin has been knocked down. These data suggest that the anti-proliferative activity of GNS-AS1411 is not the only consequence of nucleolin targeting and down-regulation.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AS1411 aptamer; Cancer; Gold nanoparticles; Nucleolin

Mesh:

Substances:

Year:  2019        PMID: 31336175     DOI: 10.1016/j.nano.2019.102060

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  5 in total

1.  Radiosensitization of breast cancer cells using AS1411 aptamer-conjugated gold nanoparticles.

Authors:  Somayeh Sadat Mehrnia; Bijan Hashemi; Seyed Javad Mowla; Maryam Nikkhah; Azim Arbabi
Journal:  Radiat Oncol       Date:  2021-02-10       Impact factor: 3.481

2.  Dacarbazine-Loaded Targeted Polymeric Nanoparticles for Enhancing Malignant Melanoma Therapy.

Authors:  Wei Xiong; Zhengdong Guo; Baoyan Zeng; Teng Wang; Xiaowei Zeng; Wei Cao; Daizheng Lian
Journal:  Front Bioeng Biotechnol       Date:  2022-02-17

3.  Toward G-Quadruplex-Based Anticancer Agents: Biophysical and Biological Studies of Novel AS1411 Derivatives.

Authors:  Anna M Ogloblina; Nunzia Iaccarino; Domenica Capasso; Sonia Di Gaetano; Emanuele U Garzarella; Nina G Dolinnaya; Marianna G Yakubovskaya; Bruno Pagano; Jussara Amato; Antonio Randazzo
Journal:  Int J Mol Sci       Date:  2020-10-21       Impact factor: 5.923

Review 4.  Progress in cancer drug delivery based on AS1411 oriented nanomaterials.

Authors:  Xin Tong; Lu Ga; Jun Ai; Yong Wang
Journal:  J Nanobiotechnology       Date:  2022-01-31       Impact factor: 10.435

5.  Anti-Proliferative Effect of Doxorubicin-Loaded AS1411 Aptamer on Colorectal Cancer Cell.

Authors:  Walaiporn Lohlamoh; Boonchoy Soontornworajit; Pichayanoot Rotkrua
Journal:  Asian Pac J Cancer Prev       Date:  2021-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.